Accelerating Alzheimer's disease drug innovations from the research pipeline to patients-Reference-Cited by-同舟云学术

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients

Published:2018-04-18 Issue:6 Volume:14 Page:833-836
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Goldman Dana P.¹,Fillit Howard²,Neumann Peter³

Affiliation:

1. Public Policy, Pharmacy, and EconomicsUniversity of Southern CaliforniaLos AngelesCAUSA

2. Founding Executive Director and Chief Science OfficerAlzheimer's Drug Discovery FoundationNew YorkNYUSA

3. Center for the Evaluation of Value and Risk in HealthInstitute for Clinical Research and Health Policy StudiesTufts Medical CenterTufts University School of MedicineBostonMAUSA

Funder

National Institutes of Health

Alzheimer's Drug Discovery Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.02.007

Reference16 articles.

1. Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest‐old

2. The Value of Delaying Alzheimer’s Disease Onset

3. Editorial: The five-five, ten-ten plan for Alzheimer's disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

2. Color Fundus Photography and Deep Learning Applications in Alzheimer’s Disease;Mayo Clinic Proceedings: Digital Health;2024-08

3. Effect of Cerebralcare Granule® combined with memantine on Alzheimer's disease;Journal of Ethnopharmacology;2024-04

4. The Structural Basis of DL0410, a Novel Multi-Target Candidate Drug for the Treatment of Alzheimer’s Disease;Crystals;2023-12-31

5. People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare;Journal of Internal Medicine;2023-12-14